Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

84.43
Delayed Data
As of Feb 24
 +0.36 / +0.43%
Today’s Change
71.84
Today|||52-Week Range
140.65
+1.44%
Year-to-Date
PRGO Regular Dividend: PRGO will begin trading ex-dividend on 03/01/17 with a $0.16 dividend payable to shareholders of record as of 03/03/17.
How Starboard Hopes to Extract Value From Tribune
Feb 22 / TheStreet.com - Paid Partner Content
Bristol-Myers Buys Back Shares, Shuffles Board
Feb 21 / TheStreet.com - Paid Partner Content
Why Big Activist Is Targeting Tribune Media
Feb 22 / TheStreet.com - Paid Partner Content
US energy stocks retreat as oil price slips
Feb 07 / FT.com - Paid Partner Content

Today’s Trading

Previous close84.07
Today’s open84.37
Day’s range83.07 - 84.80
Volume1,284,171
Average volume (3 months)1,732,269
Market cap$12.1B
Dividend yield0.76%
Data as of 4:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.40%
Revenue growth (last year)+36.36%
P/E ratio17.8
Price/Sales3.82
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+0.96+0.52%
BMRNBiomarin Pharmaceuti...-1.78-1.99%
SGENSeattle Genetics Inc-0.34-0.54%
JAZZJazz Pharmaceuticals...+0.71+0.52%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$1.62
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs